The Analysis of Heart Rate Variability With 24hrs Holter ECG and Serum Cardiac Fibrosis Markers in Critical Illness Patients Who Are With Cardiogenic Shock, With ECMO or IABP Support, or With APACH II Score >25)

Cardiogenic Shock, Clinical Trial

Official title: The Analysis of Heart Rate Variability With 24hrs Holter ECG and Serum Cardiac Fibrosis Markers in Critical Illness Patients Who Are With Cardiogenic Shock, With ECMO or IABP Support, or With APACH II Score >25)

Status Completed

Clinical Trial Summary

The study is to show the prognostic factor of HRV parameter and cardiac fibrosis markers in critical illness patients

Clinical Trial Description

The analysis of Heart Rate Variability with 24hrs Holter ECG and serum cardiac fibrosis markers in critical illness patients who are with cardiogenic shock, with ECMO or IABP support, or with APACH II score >25) ;

Study Design

Observational Model: Case Control, Time Perspective: Cross-Sectional

Related Conditions & MeSH terms

• Cardiogenic Shock,
• Critical Illness
• Shock
• Shock, Cardiogenic
• With APACH II Score >25)
• With ECMO or IABP Support,

• NCT number: NCT01993745
• Study type: Observational
• Source: National Taiwan University Hospital
• Status: Completed
• Phase: N/A
• Start date: May 2008
• Completion date: December 2009